Kimia Biosciences Ltd Financial Ratios
KIMIABL · Healthcare · Current price ₹31
P/E ratio
19.4x
P/B ratio
7.9x
ROE
41.9%
ROCE
22.8%
Debt / Equity
1.96
Dividend yield
0.0%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 19.4x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 7.9x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 41.9% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 22.8% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 1.96 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with Kimia Biosciences Ltd's latest numbers.
Kimia Biosciences Ltd profitability
Kimia Biosciences Ltd generates a return on equity of 41.9% and a return on capital employed of 22.8%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 1.96 and a P/E of 19.4x, Kimia Biosciences Ltd is carrying meaningful debt. Our overall business-quality score for the company is 4.3 / 10.
Understand the ratios
More on Kimia Biosciences Ltd
DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.